J. Exp. Med., Volume 189, Number 6, March 15, 1999 907-918

An Inflammatory Polypeptide Complex from Staphylococcus epidermidis: Isolation and Characterization

By Christopher Mehlin, Catherine M. Headley,^* and Seymour J. Klebanoff^*

From the ^* Department of Medicine and the  Department of Pathobiology, University of  Washington, Seattle, Washington 98195

Staphylococcus epidermidis releases factors that activate the HIV-1 long terminal repeat, induce cytokine release, and activate nuclear factor B in cells of macrophage lineage. The active material had a mass of 34,500 daltons, was inactivated by proteases and partitioned into the phenol layer on hot aqueous phenol extraction, and thus was termed phenol-soluble modulin (PSM). High performance liquid chromatography (HPLC) of crude PSM yielded two peaks of activity designated PSM peak 1 and peak 2. MALDI-TOF (matrix-assisted laser desorption ionization-time of flight) mass spectroscopy indicated the presence of two components in peak 1, which were designated PSM and PSM. Peak 2 contained a single component, designated PSM. Separation of PSM and PSM in peak 1 could be achieved by a second HPLC procedure. The structure of each component was determined by amino acid sequence analysis and identification and sequencing of their genes. PSM, PSM, and PSM were 22-, 44-, and 25-amino acid, respectively, strongly hydrophobic polypeptides. PSM was identified as Staphylococcus epidermidis delta toxin, whereas PSM and PSM exhibited more distant homology to previously described staphylococcal toxins. They appeared to exist as a complex or aggregate with activity greater than the component parts. The properties of the S. epidermidis PSMs suggest that they may contribute to the systemic manifestations of Gram-positive sepsis.

Staphylococcus epidermidis;  HIV-1 long terminal repeat;  phenol-soluble modulin;  inflammatory polypeptide;  nuclear factor B

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jones, R. C., Deck, J., Edmondson, R. D., Hart, M. E. (2008). Relative Quantitative Comparisons of the Extracellular Protein Profiles of Staphylococcus aureus UAMS-1 and Its sarA, agr, and sarA agr Regulatory Mutants Using One-Dimensional Polyacrylamide Gel Electrophoresis and Nanocapillary Liquid Chromatography Coupled with Tandem Mass Spectrometry . J. Bacteriol. 190: 5265-5278 [Abstract] [Full Text]  
• Cassat, J., Dunman, P. M., Murphy, E., Projan, S. J., Beenken, K. E., Palm, K. J., Yang, S.-J., Rice, K. C., Bayles, K. W., Smeltzer, M. S. (2006). Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390.. Microbiology 152: 3075-3090 [Abstract] [Full Text]  
• Fournier, B., Philpott, D. J. (2005). Recognition of Staphylococcus aureus by the Innate Immune System. Clin. Microbiol. Rev. 18: 521-540 [Abstract] [Full Text]  
• Lentschat, A., Karahashi, H., Michelsen, K. S., Thomas, L. S., Zhang, W., Vogel, S. N., Arditi, M. (2005). Mastoparan, a G Protein Agonist Peptide, Differentially Modulates TLR4- and TLR2-Mediated Signaling in Human Endothelial Cells and Murine Macrophages. J. Immunol. 174: 4252-4261 [Abstract] [Full Text]  
• Dresselhaus, T., Amien, S., Marton, M., Strecke, A., Brettschneider, R., Cordts, S. (2005). TRANSPARENT LEAF AREA1 Encodes a Secreted Proteolipid Required for Anther Maturation, Morphogenesis, and Differentiation during Leaf Development in Maize. Plant Cell 17: 730-745 [Abstract] [Full Text]  
• Equils, O., Shapiro, A., Madak, Z., Liu, C., Lu, D. (2004). Human Immunodeficiency Virus Type 1 Protease Inhibitors Block Toll-Like Receptor 2 (TLR2)- and TLR4-Induced NF-{kappa}B Activation. Antimicrob. Agents Chemother. 48: 3905-3911 [Abstract] [Full Text]  
• Majcherczyk, P. A., Rubli, E., Heumann, D., Glauser, M. P., Moreillon, P. (2003). Teichoic Acids Are Not Required for Streptococcus pneumoniae and Staphylococcus aureus Cell Walls To Trigger the Release of Tumor Necrosis Factor by Peripheral Blood Monocytes. Infect. Immun. 71: 3707-3713 [Abstract] [Full Text]  
• Equils, O., Schito, M. L., Karahashi, H., Madak, Z., Yarali, A., Michelsen, K. S., Sher, A., Arditi, M. (2003). Toll-Like Receptor 2 (TLR2) and TLR9 Signaling Results in HIV-Long Terminal Repeat Trans-Activation and HIV Replication in HIV-1 Transgenic Mouse Spleen Cells: Implications of Simultaneous Activation of TLRs on HIV Replication. J. Immunol. 170: 5159-5164 [Abstract] [Full Text]  
• Bulut, Y., Faure, E., Thomas, L., Equils, O., Arditi, M. (2001). Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling. J. Immunol. 167: 987-994 [Abstract] [Full Text]  
• Liles, W. C., Thomsen, A. R., O'Mahony, D. S., Klebanoff, S. J. (2001). Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J. Leukoc. Biol. 70: 96-102 [Abstract] [Full Text]  
• Hajjar, A. M., O'Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., Wilson, C. B. (2001). Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin. J. Immunol. 166: 15-19 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS